The obesity-cancer link: lessons learned from a fatless mouse

Area of Science:

• Oncology
• Metabolic Syndrome
• Molecular Biology

Background:

• The established link between obesity and cancer is often attributed to white adipose tissue and its secreted adipokines.
• However, recent studies challenge this dogma, suggesting alternative mechanisms may drive cancer development in obesity.

Purpose of the Study:

• To re-evaluate the risk factors contributing to the obesity-cancer association.
• To investigate the role of insulin resistance and inflammation versus adipokines in obesity-driven carcinogenesis.

Main Methods:

• Utilized fatless A-Zip/F1 mice, characterized by undetectable adipokine levels but accelerated tumor formation.
• Analyzed metabolic and inflammatory profiles, including insulin, IGF-1, and cytokine levels, alongside key signaling pathways in these mice.

Main Results:

• A-Zip/F1 mice, despite lacking adipokines, exhibited accelerated tumor development, indicating adipokines are not essential for this effect.
• These mice displayed hallmarks of metabolic dysfunction, including diabetes, elevated insulin, IGF-1, and proinflammatory cytokines, alongside activated cancer-associated signaling pathways.

Conclusions:

• The current understanding of the obesity-cancer link, focusing solely on adipokines, may be incomplete.
• Insulin resistance and inflammation pathways emerge as potentially more critical targets for therapeutic and preventive strategies against obesity-related cancers.